Pacira | PCRX - القيمة السوقية





القيمة السوقية تغيير تاريخ
Astellas Pharma JPY 3.94T 622.52B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cara Therapeutics USD 30M 336M 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
J&J USD 611.36B 32.21B 2026-06
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Novo Nordisk A/S DKK 1.4T 373.76B 2026-06
Pacira USD 998M 83M 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Supernus Pharmaceuticals USD 2.7B 277M 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Xeris Pharmaceuticals USD 1000M 303M 2026-03
Zoetis USD 30.13B 19.58B 2026-06